Skip to main content

Table 1 Population demographics and histological features reported as mean (SD) or prevalence (percentage)

From: A critical review of the chest CT scans performed to detect asymptomatic synchronous metastasis in new and recurrent breast cancers

Features

Mean/prevalence

Age (in years at the time of surgery)

61 (13.1)

Histologic type

 DCIS

58 (8)

 IDC

553 (77)

 ILC

88 (12)

 Others

27 (3)

Clinical stage

 Stage 0 (in situ)#

51 (7)

 Stage I

224 (31)

 Stage II

275 (38)

 Stage III

61 (8)

 Stage IV

7 (1)

 NACT

30 (4)

 Recurrence

56 (8)

 Benign and others

22 (3)

Histological grade of invasive cancer

 Grade 1

100 (14)

 Grade 2

261 (36)

 Grade 3

261 (36)

 Others

104 (15)

Other histological features*

 Estrogen receptor positive

550 (85)

 Progesterone receptor positive

478 (74)

 HER2 amplified

83 (13)

 LVI positive

135 (21)

 Node positive

241 (39)

  1. DCIS ductal carcinoma in situ, LCIS lobular carcinoma in situ, IDC invasive ductal cancer, ILC invasive lobular cancer, NACT neoadjuvant chemotherapy, HER2 human epidermal growth factor receptor 2, LVI lymphovascular invasion
  2. *These histological features are calculated on available data on invasive disease only
  3. #In situ disease is composed of both DCIS and LCIS; nine of the DCIS were recurrent and hence counted under recurrences in clinical stage